XML 50 R33.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Accounting Policies [Abstract] |
Schedule Of Impact Of Restatement On Certain Line Items And Balance Sheet |
Consolidated Statements of Income (loss) |  | Year ended December 31, 2022 |  |  | Consolidated Balance Sheets |  | December 31, 2022 |
|  | As previously reported |  |  | Adjustment |  |  | As revised |  |  |  |  | As previously reported |  |  | Adjustment |  |  | As revised |
|  | U.S $ in millions (except per share amounts) |  |  |  |  | U.S $ in millions (except per share amounts) |
Other asset impairments, restructuring and other items |  | $ | 414 |  |  |  | 98 |  |  |  | 512 |  |  | Deferred income taxes |  | $ | 1,453 |  |  |  | 5 |  |  |  | 1,458 |
Operating income (loss) |  |  | (2,099 | ) |  |  | (98 | ) |  |  | (2,197 | ) |  | Total assets |  |  | 44,006 |  |  |  | 5 |  |  |  | 44,011 |
Income (loss) before income taxes |  |  | (3,065 | ) |  |  | (98 | ) |  |  | (3,163 | ) |  | Other taxes and long-term liabilities |  |  | 3,847 |  |  |  | 98 |  |  |  | 3,945 |
Income taxes (benefit) |  |  | (638 | ) |  |  | (5 | ) |  |  | (643 | ) |  | Total long-term liabilities |  |  | 23,846 |  |  |  | 98 |  |  |  | 23,944 |
Net income (loss) |  |  | (2,406 | ) |  |  | (93 | ) |  |  | (2,499 | ) |  | Total liabilities |  |  | 35,315 |  |  |  | 98 |  |  |  | 35,413 |
Net income (loss) attributable to Teva |  |  | (2,353 | ) |  |  | (93 | ) |  |  | (2,446 | ) |  | Teva shareholders’ equity: |  |  |  |  |  |  |  |  |  |  |  |
Earnings (loss) per share attributable to ordinary shareholders: |  |  |  |  |  |  |  |  |  |  |  |  |  | Accumulated deficit |  |  | (12,882 | ) |  |  | (93 | ) |  |  | (12,975 | )
Basic |  | $ | (2.12 | ) |  |  | (0.08 | ) |  |  | (2.20 | ) |  | Total equity |  |  | 8,691 |  |  |  | (93 | ) |  |  | 8,598 |
Diluted |  | $ | (2.12 | ) |  |  | (0.08 | ) |  |  | (2.20 | ) |  | Total liabilities and equity |  | $ | 44,006 |  |  |  | 5 |  |  |  | 44,011 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration